Dashboard
Manage Tickers

TNGX Tango Therapeutics, Inc.

Nasdaq tangotx.com


$ 8.67 $ 0.17 (2 %)    

Thursday, 20-Nov-2025 13:52:27 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 588.69 $ -22.97 (-3.76 %)
DIA $ 458.08 $ -8.60 (-1.84 %)
SPY $ 654.54 $ -18.36 (-2.73 %)
TLT $ 89.25 $ 0.26 (0.3 %)
GLD $ 373.17 $ -1.95 (-0.52 %)
$ 8.285
$ 8.50
$ 8.68 x 49
$ 8.66 x 105
$ 8.50 - $ 9.06
$ 1.03 - $ 9.70
5,343,747
na
1.12B
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-18-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-27-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-28-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
20 03-31-2021 12-31-2020 10-K
21 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wolfe-research-initiates-coverage-on-tango-therapeutics-with-peer-perform-rating
Wolfe Research Initiates Coverage On Tango...
11/18/2025 17:19:29

Wolfe Research analyst Kalpit Patel initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Peer Perform rating.

b-riley-securities-maintains-buy-on-tango-therapeutics-raises-price-target-to-14
B. Riley Securities Maintains Buy on Tango...
11/18/2025 17:07:32

B. Riley Securities analyst Yuan Zhi maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from ...

tango-therapeutics-september-30-1528m-in-cash-cash-equivalents-and-marketable-securities-in-addition-to-212m-in-october-financing-is-expected-to-extend-cash-runway-into-2028
Tango Therapeutics' September 30 $152.8M I...
11/04/2025 14:03:56

tango-therapeutics-q3-2025-eps-014-beats-005-estimate-sales-53811m-beat-37142m-estimate
Tango Therapeutics Q3 2025 EPS $0.14 Beats...
11/04/2025 14:01:32

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

a-peek-at-tango-therapeuticss-future-earnings
A Peek at Tango Therapeutics's Future Earn...
11/03/2025 19:02:56

guggenheim-maintains-buy-on-tango-therapeutics-raises-price-target-to-12
Guggenheim Maintains Buy on Tango Therapeu...
10/24/2025 12:01:55

Guggenheim analyst Charles Zhu maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $10 to...

tango-therapeutics-touts-encouraging-data-from-early-stage-cancer-trial-raises-capital-to-fund-advancement
Tango Therapeutics Touts Encouraging Data ...
10/23/2025 15:17:16

Tango Therapeutics Inc. (NASDAQ:TNGX) revealed data from its ongoing Phase 1/2 study of vopimetostat (TNG462) in patients with ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/23/2025 12:07:49

tango-therapeutics-announces-225m-financing-prices-210m-offering-of-21m-shares-at-866-and-32m-pre-funded-warrants-at-8659
Tango Therapeutics Announces $225M Financi...
10/23/2025 11:23:38

Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next...

tango-therapeutics-new-drug-doubles-response-rates-in-deadly-pancreatic-cancer-trial
Tango Therapeutics' New Drug Doubles Respo...
10/23/2025 11:06:08

Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next...

tango-therapeutics-to-showcase-initial-clinical-results-for-tng260-in-combination-with-pembrolizumab-in-stk11-mutant-lung-cancer-at-sitc-annual-meeting
Tango Therapeutics To Showcase Initial Cli...
10/06/2025 11:09:54

piper-sandler-initiates-coverage-on-tango-therapeutics-with-overweight-rating-announces-price-target-of-11
Piper Sandler Initiates Coverage On Tango ...
08/19/2025 11:51:28

Piper Sandler analyst Kelsey Goodwin initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overweight rating and ann...

guggenheim-maintains-buy-on-tango-therapeutics-raises-price-target-to-10
Guggenheim Maintains Buy on Tango Therapeu...
08/06/2025 15:00:20

Guggenheim analyst Michael Schmidt maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $8...

tango-therapeutics-q2-eps-035-beats-036-estimate-sales-3181m-miss-6679m-estimate
Tango Therapeutics Q2 EPS $(0.35) Beats $(...
08/05/2025 11:05:35

Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

tango-therapeutics-doses-first-patient-in-phase-12-combo-trial-with-revolution-medicines-ras-inhibitors-for-mtap-deleted-cancers
Tango Therapeutics Doses First Patient In ...
06/27/2025 11:05:38

sarepta-therapeutics-kulr-technology-group-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Sarepta Therapeutics, KULR Technology Grou...
06/16/2025 12:38:15

quanex-building-products-manchester-united-byrna-technologies-and-other-big-stocks-moving-higher-on-friday
Quanex Building Products, Manchester Unite...
06/06/2025 14:20:02

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/29/2025 21:06:36

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION